BU BÖLÜM HAKKINDA

ingilizce
Amerika Birleşik Devletleri

TRANSKRİPT 🔗

SON BÖLÜMLERİ ARA

ASTRO 2015 için geçmiş bölümleri ara.

BU PODCAST'IN DİĞER BÖLÜMLERİ

Dr Hong talks to ecancertv at ASTRO 2015 about a prospective, open-label phase II, study of proton-based stereotactic body radiotherapy (SBRT) in patients with liver metastases. The study findings showed that proton SBRT was associated with high rates of local control and that there was a favourab…
Dr Abazeed talks to ecancertv at ASTRO 2015 about research being conducted at the Cleveland Clinic looking at whether it is possible to use genomic parameters to predict how tumours will respond to radiation therapy. In the interview he highlights that there is an underlying genetic diversity of c…
Dr Hoyer talks to ecancertv at ASTRO 2015 about his lecture during the ASTRO/ESTRO Joint Session 'Novel treatment approaches for oligometastases'. In the interview he provides background on how oligometastases have been managed in the past and how stereotactic body radiation therapy (SBRT) is bein…
Mr DiGiaimo talks to ecancertv at ASTRO 2015 about some of his research highlights and the potential economic considerations of using newer radiation technologies over conventional standards.
Dr Hong talks to ecancertv about one of the nursing sessions held at ASTRO 2015 that looked at the care of patients receiving chemoradiation. In the interview he outlines that the aims of the session were to provide an overview of the data and rationale for why certain chemoradiation strategies we…
Feragatname: Bu sayfaya yerleştirilmiş podcast ve sanat eserleri, sahibinin mülkiyetinde olan ve Listen Notes, Inc.'e bağlı olmayan veya tarafından onaylanmayan ecancer.org'e aittir.